All public logs

Combined display of all available logs of Canonica AI. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).

• 13:53, 1 June 2024 Ai talk contribs created page Cemiplimab (Created page with "== Introduction == Cemiplimab is a fully human monoclonal antibody that targets the programmed cell death protein 1 (PD-1) receptor. It is used in the treatment of various cancers, particularly cutaneous squamous cell carcinoma (CSCC) and non-small cell lung cancer (NSCLC). Cemiplimab works by inhibiting the interaction between PD-1 and its ligands, PD-L1 and PD-L2, thereby enhancing the immune system's ability to recognize and destroy cancer cells. == Mechanism of Act...")